BNP Paribas Financial Markets Purchases New Stake in Revvity, Inc. (NYSE:RVTY)

BNP Paribas Financial Markets purchased a new position in Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 110,134 shares of the company's stock, valued at approximately $12,039,000. BNP Paribas Financial Markets owned approximately 0.09% of Revvity as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Teacher Retirement System of Texas purchased a new stake in Revvity in the fourth quarter worth about $58,414,000. Reynders McVeigh Capital Management LLC purchased a new stake in shares of Revvity during the fourth quarter worth about $734,000. Smithfield Trust Co purchased a new stake in shares of Revvity during the fourth quarter worth about $49,000. Gladius Capital Management LP grew its position in shares of Revvity by 85.3% during the fourth quarter. Gladius Capital Management LP now owns 430 shares of the company's stock worth $47,000 after purchasing an additional 198 shares in the last quarter. Finally, Arcadia Investment Management Corp MI purchased a new stake in shares of Revvity during the fourth quarter worth about $219,000. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Stock Up 1.6 %

NYSE RVTY traded up $1.77 on Friday, reaching $110.23. 1,061,545 shares of the stock traded hands, compared to its average volume of 844,554. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $131.96. The company has a fifty day moving average price of $104.17 and a 200-day moving average price of $101.52. The company has a market cap of $13.60 billion, a price-to-earnings ratio of 91.10, a PEG ratio of 2.79 and a beta of 1.09. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.92 and a current ratio of 2.23.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, April 29th. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.94 by $0.04. Revvity had a return on equity of 7.37% and a net margin of 5.49%. The business had revenue of $649.90 million for the quarter, compared to the consensus estimate of $646.83 million. During the same period last year, the business posted $1.01 EPS. The business's revenue was down 3.7% compared to the same quarter last year. As a group, research analysts forecast that Revvity, Inc. will post 4.66 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 9th. Stockholders of record on Friday, July 19th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, July 19th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.25%. Revvity's payout ratio is 23.14%.

Analyst Ratings Changes

Several analysts recently issued reports on RVTY shares. KeyCorp increased their target price on Revvity from $110.00 to $126.00 and gave the stock an "overweight" rating in a research report on Friday, February 2nd. Robert W. Baird raised their price target on Revvity from $126.00 to $127.00 and gave the company an "outperform" rating in a report on Tuesday, April 30th. Stifel Nicolaus raised their price target on Revvity from $95.00 to $110.00 and gave the company a "hold" rating in a report on Friday, February 2nd. TD Cowen raised their price target on Revvity from $123.00 to $130.00 and gave the company a "buy" rating in a report on Tuesday, April 30th. Finally, Barclays raised their price target on Revvity from $92.00 to $105.00 and gave the company an "equal weight" rating in a report on Thursday, January 25th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $118.17.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.